Ralph Grosswald - Dec 12, 2022 Form 4 Insider Report for Virios Therapeutics, Inc. (VIRI)

Role
SVP OF OPERATIONS
Signature
/s/ Greg Duncan, Attorney-in-Fact
Stock symbol
VIRI
Transactions as of
Dec 12, 2022
Transactions value $
$0
Form type
4
Date filed
12/14/2022, 05:31 PM
Previous filing
Jun 30, 2022
Next filing
Feb 28, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VIRI Stock Option (right to buy) Award $0 +80K $0.00 80K Dec 12, 2022 Common Stock 80K $0.28 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests one-third on December 12, 2023 and 1/24th monthly thereafter.